Sign In

Communications of the ACM

ACM News

First Crispr Clinical Trial Gets Green Light from ­S Panel

View as: Print Mobile App Share:
Human T cells (blue), cancer cells (pink)

Human T cells (blue) will soon be modified using the CRISPR technique in a clinical trial to attack cancer cells (pink).

Credit: Steve Gschmeissner/SPL

CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials.

From Nature
View Full Article



No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account